Silexion Therapeutics CORP (SLXNW) SEC Filings — 2025
45 SEC filings for Silexion Therapeutics CORP (SLXNW) in 2025.
Filings
- Silexion Therapeutics Corp. Files 8-K — 8-K · Dec 16, 2025
- Silexion Therapeutics Files 8-K — 8-K · Dec 2, 2025
- Silexion Therapeutics Files 8-K — 8-K · Nov 25, 2025
- Silexion Boosts Cash, Equity Amidst R&D Cuts and Reverse Splits — 10-Q · Nov 12, 2025
- Silexion Therapeutics Files 8-K — 8-K · Sep 30, 2025
- Silexion Therapeutics Corp. Files 8-K for Material Agreement — 8-K · Sep 26, 2025
- Silexion Therapeutics to Acquire 03 Life Sciences — 8-K · Sep 25, 2025
- Silexion Therapeutics Reports Equity Issuance — 8-K · Sep 15, 2025
- Silexion Therapeutics Corp. Files Material Definitive Agreement — 8-K · Sep 12, 2025
- Silexion Therapeutics Files 8-K — 8-K · Sep 11, 2025
- Silexion Launches Best-Efforts Offering Amidst Reverse Splits — S-1 · Sep 5, 2025
- Silexion Therapeutics Corp. Files 8-K — 8-K · Sep 4, 2025
- Silexion Therapeutics Files 8-K — 8-K · Sep 2, 2025
- Silexion Files S-1 for Resale of 314,859 Shares Amidst Funding Needs — S-1 · Aug 26, 2025
- Silexion Therapeutics Files 8-K — 8-K · Aug 20, 2025
- Silexion Therapeutics Files 8-K with Corporate Updates — 8-K · Aug 19, 2025
- Silexion Therapeutics Files Proxy Materials — DEFA14A · Aug 12, 2025
- Silexion Therapeutics Files 8-K: Agreements & Equity Sales — 8-K · Aug 1, 2025
- Silexion Seeks Shareholder Nod for 500%+ Capital Increase — DEF 14A · Jul 31, 2025
- Silexion Therapeutics to be Acquired by 03 Life Sciences — 8-K · Jul 29, 2025
- Silexion Therapeutics Faces Delisting Notice — 8-K · Jul 21, 2025
- Silexion Therapeutics Files 8-K, Former Biomotion Sciences — 8-K · Jul 16, 2025
- Silexion Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jul 14, 2025
- Silexion Therapeutics Files 8-K — 8-K · Jul 9, 2025
- Silexion Therapeutics Files 8-K/A Amendment — 8-K/A · Jul 8, 2025
- Silexion Therapeutics Files Proxy Statement — DEFA14A · Jul 7, 2025
- Silexion Therapeutics Files Proxy Materials — DEFA14A · Jun 23, 2025
- Silexion Sets July 7 Shareholder Meeting for Director, Auditor Votes — DEF 14A · Jun 16, 2025
- Silexion Therapeutics Raises $1.3M in Share Sale — 8-K · Jun 3, 2025
- Silexion Therapeutics Files 8-K on Share and Warrant Activity — 8-K · May 29, 2025
- Silexion Therapeutics Receives NASDAQ Delisting Notice — 8-K · May 23, 2025
- Silexion Therapeutics Files 8-K — 8-K · May 21, 2025
- Silexion Therapeutics Files 10-Q Post Reverse Split — 10-Q · May 13, 2025
- Silexion Therapeutics Files 8-K with Financials — 8-K · Apr 23, 2025
- Silexion Therapeutics Files 8-K, Notes Warrants — 8-K · Mar 28, 2025
- Silexion Therapeutics Files S-1/A, Reverse Stock Split — S-1/A · Mar 27, 2025
- Silexion Therapeutics CORP 10-K Filing — 10-K · Mar 18, 2025
- Silexion Therapeutics Corp. Files 8-K for Material Definitive Agreement — 8-K · Mar 14, 2025
- Silexion Therapeutics Files 8-K with Financials & Warrants — 8-K · Mar 5, 2025
- Silexion Therapeutics Files S-1 — S-1 · Feb 12, 2025
- Silexion Therapeutics Corp. Files 8-K: Material Agreement & Equity Sales — 8-K · Jan 30, 2025
- Silexion Therapeutics Files 8-K on Warrants — 8-K · Jan 28, 2025
- Silexion Therapeutics Corp. Enters Material Definitive Agreement — 8-K · Jan 17, 2025
- Silexion Therapeutics Corp. Files 8-K — 8-K · Jan 15, 2025
- Silexion Therapeutics Files 8-K on Financials — 8-K · Jan 14, 2025